🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, doxorubici...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00726700
Treatments Being Tested
This study is researching an experimental drug called odronextamab, referre...
Status
Recruiting
Location
Mayo Clinic - Arizona
Start Date
2023-12-13
Trial ID
NCT06091865
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Start Date
2005-09
Trial ID
NCT00101010
This is a multicenter China-only study to investigate the PK, efficacy and ...
Status
Completed
Location
Peking University Third Hospital
Start Date
2021-02-24
Trial ID
NCT04660799
This study is researching an experimental drug called odronextamab, referre...
Status
Active Not Recruiting
Location
Boca Raton Clinical Research (BRCR) Global
Start Date
2023-11-14
Trial ID
NCT06097364
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of carfilzomib...
Status
Completed
Location
Roswell Park Comprehensive Cancer Center
Start Date
2015-01-28
Trial ID
NCT02073097
This two-stage, multi-center, randomized, controlled, open-label study will...
Status
Completed
Location
Gosford Hospital; Cancer Care Services
Start Date
2011-02-15
Trial ID
NCT01200758
Treatments Being Tested
This phase III trial compares the effects of nivolumab with chemo-immunothe...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-10-05
Trial ID
NCT04759586
Treatments Being Tested
A Phase II, open-label, two-arm, multicenter study evaluating the combinati...
Status
Not Yet Recruiting
Location
Zuckerberg San Francisco General
Start Date
2026-09-15
Trial ID
NCT07588698